Acquired immune deficiency syndrome: the glucocorticoid solution

Area of Science:

• Immunology
• Endocrinology
• Virology

Background:

• The "cortisol connection" theory links glucocorticoid metabolism, immune function, and human immunodeficiency virus (HIV).
• HIV's gp 120 interacts with cellular receptors, potentially disrupting immune signaling pathways involving interleukin-1.
• Elevated cortisol levels are observed in HIV infection, suggesting a dysregulation of the hypothalamic-pituitary-adrenal axis.

Purpose of the Study:

• To explore the role of glucocorticoid metabolism in HIV pathogenesis.
• To investigate the mechanism by which HIV may manipulate cortisol production.
• To identify potential therapeutic targets based on the interaction between HIV and the glucocorticoid system.

Main Methods:

• Analysis of the interaction between HIV gp 120 and cellular receptors.
• Assessment of interleukin-1 and cortisol levels in HIV-infected individuals.
• Investigation of glucocorticoid-responsive elements within the HIV genome.
• Evaluation of HIV infection susceptibility in glucocorticoid-resistant cells and patients.

Main Results:

• HIV gp 120 appears to interfere with interleukin-1 signaling, impacting T-lymphocyte proliferation and cortisol release.
• HIV infection is associated with cortisol excess and upregulation of adrenocorticotrophic hormone-related messenger RNA.
• Glucocorticoid-resistant lymphoid cells and patients exhibit resistance to HIV infection.
• The HIV genome contains glucocorticoid-responsive elements that may regulate viral replication.

Conclusions:

• HIV pathogenesis involves a unique glucocorticoid metabolic route, contributing to cortisol excess.
• The interplay between HIV and glucocorticoids offers a novel perspective on disease mechanisms.
• Targeting the "cortisol connection" presents a promising avenue for developing new HIV therapies.